Table 1 Distribution of baseline characteristics, peri-operative and post-operative outcomes of patients in the treatment groups
Mictalase group (n = 56) | Control group (n = 55) | p value | |
|---|---|---|---|
Patients’ baseline characteristics | |||
Age, years | 65 (61–75) | 69 (63–74) | 0.2 |
PVol, ml | 73.5 (50.0–90.0) | 70.0 (50.0–100.0) | 0.7 |
Qmax, ml/s | 10.0 (8.0–13.7) | 9.4 (7.0–12.1) | 0.4 |
PVR, ml | 65 (40–100) | 90 (70–110) | 0.5 |
IPSS | 21 (16–26) | 23 (19–28) | 0.3 |
QoL | 5 (4–5) | 5 (4–6) | 0.5 |
Intra-operative data | |||
Operative time, min | 88 (70–125) | 102 (75–138) | 0.6 |
Energy delivered, joules | 58 k (42–83 k) | 60 k (44–80 k) | 0.9 |
Enucleated adenoma, grams | 63.5 (40–80) | 60.0 (40–85) | 0.7 |
Peri-operative data | |||
Length of stay, days | 3 (2–3) | 3 (3–4) | 0.1 |
Catheterization time, days | 3 (2–5) | 3 (2–5) | 0.1 |
Complications | 2 (3.6) | 3 (5.4) | 0.6 |